Picture of Bioatla logo

BCAB — Bioatla News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Bioatla Inc expected to post a loss of 69  cents a share - Earnings Preview

* Bioatla Inc  BCAB.OQ   BCAB.O  is expected to show a rise
in
quarterly revenue when it reports  results on August 9. 
    * The San Diego California-based  company is expected to
report  a
60.0% increase in revenue to $400 thousand from $250 thousand a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Bioatla Inc is for
a loss
of 69 cents per share. For the same quarter last year, the
company reported a loss of 90 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bioatla Inc
is
$25​, above​ its last closing price of $3.94. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.67       -0.67      -0.65     Beat    3
 Dec. 31 2022  -0.63       -0.63      -0.62     Beat    1.2
 Sep. 30 2021  -0.63       -0.64      -0.68     Missed  -5.7​
 Jun. 30 2021  -0.60       -0.58      -0.90     Missed  -53.9
 ​​Mar.        -0.49       -0.52      -0.56     Missed  -7.1
 31 2021                                                
 Dec. 31 2020  -0.78       -0.78      -1.50     Missed  -92.6​
 This summary was machine generated August 6 at 02:08 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Bioatla

See all news